Beijing Tiantan Biological Products Corporation Limited provided earnings guidance for the first quarter of 2016. For the quarter, the company predicts that it will suffer a loss in its business performance, with its net loss owned by shareholders of listed company to be about RMB 0.7 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.3 CNY | -1.97% | -2.37% | -5.30% |
May. 16 | Bank of China Executive Vice President Steps Down | MT |
May. 02 | ICBC, CCB Name Deputy Party Secretaries | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.30% | 6.82B | |
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.10% | 34.26B | |
+53.99% | 25.27B | |
-9.41% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- 600161 Stock
- News Beijing Tiantan Biological Products Co., Ltd.
- Beijing Tiantan Biological Products Corporation Limited Provides Earnings Guidance for the First Quarter of 2016